Table 4.
Correlations between transplantation rate and clinicopathological parameters
| Clinicopathological features | No. of patients (%) | Transplantation rate (%) | P |
|---|---|---|---|
| Gender | 0.483 | ||
| Female | 14 (53.8%) | 50.0% (7/14) | |
| Male | 12 (46.2%) | 25.0% (3/12) | |
| Age (years) | 0.191 | ||
| <60 | 12 (46.2%) | 25.0% (3/12) | |
| ≥60 | 14 (53.8%) | 50.0% (7/14) | |
| Smoking history | 0.124 | ||
| No | 19 (73.1%) | 47.4% (9/19) | |
| Yes | 7 (26.9%) | 14.3% (1/7) | |
| History of alcohol consumption | 0.049 | ||
| No | 21 (80.8%) | 47.6% (10/21) | |
| Yes | 5 (19.2%) | 0.0% (0/5) | |
| Tumor size (cm) | 0.420 | ||
| <3.8 | 13 (50.0%) | 30.8% (4/13) | |
| ≥3.8 | 13 (50.0%) | 46.2% (6/13) | |
| Tumor location | 0.420 | ||
| Head | 8 (30.8%) | 50.0% (4/8) | |
| Body/tail | 18 (69.2%) | 33.3% (6/18) | |
| Vascular thrombosis | 0.315 | ||
| No | 15 (57.7%) | 46.7% (7/15) | |
| Yes | 11 (42.3%) | 27.3% (3/11) | |
| Nerve invasion | 0.192 | ||
| No | 9 (34.6%) | 55.6% (5/9) | |
| Yes | 17 (65.4%) | 29.4% (5/17) | |
| Differentiation | 0.508 | ||
| Moderate | 20 (76.9%) | 35.0% (7/20) | |
| Poor | 6 (23.1%) | 50.0% (3/6) | |
| TNM stage | 0.756 | ||
| I-II | 12 (46.2%) | 41.7% (5/12) | |
| III-IV | 14 (53.8%) | 35.7% (5/14) | |
| Lymph node metastasis | 0.619 | ||
| Present | 12 (46.2%) | 33.3% (4/12) | |
| Absent | 14 (53.8%) | 42.9% (6/14) | |
| Distant metastasis | 0.529 | ||
| Present | 1 (3.8%) | 0.0% (0/1) | |
| Absent | 25 (96.2%) | 40.0% (10/25) | |
| CA19-9 (U/ml) | 0.780 | ||
| <1400 | 19 (73.1%) | 36.8% (7/19) | |
| ≥1400 | 7 (26.9%) | 42.9% (3/7) | |
| CEA (ng/ml) | 0.102 | ||
| <17 | 22 (84.6%) | 31.9% (7/22) | |
| ≥17 | 4 (15.4%) | 75.0% (3/4) | |
| CA72-4 (U/ml) | 0.946 | ||
| <8 | 18 (69.2%) | 38.9% (7/18) | |
| ≥8 | 8 (30.8%) | 37.5% (3/8) | |
| CA242 (U/ml) | 0.235 | ||
| <90 | 19 (73.1%) | 31.6% (6/19) | |
| ≥90 | 7 (26.9%) | 57.1% (4/7) |